Sign in

You're signed outSign in or to get full access.

Avi Katz

Chairman of the Board at QTIH
Board

About Avi Katz

Dr. Avi S. Katz, age 67, serves as Chairman of the Board of QT Imaging Holdings, Inc. (QTIH) and has been a Class III director since 2024 . He is a technologist and serial SPAC sponsor with ~35 years of executive experience across TMT, including founding/leading GigPeak (sold to IDT for $250M cash in 2017) and sponsoring multiple GigCapital vehicles and de‑SPACs (Kaleyra, UpHealth, Lightning eMotors, BigBear.ai) . Dr. Katz holds a B.Sc. and Ph.D. in Materials from Technion and earlier served at AT&T Bell Labs; he is also a graduate of the Israeli Naval Academy and the U.S. Naval ASW program . Notably, he is married to QTIH’s CEO and director, Dr. Raluca Dinu, which the Board discloses as a family relationship; the Board does not deem Dr. Katz independent under Nasdaq rules .

Past Roles

OrganizationRoleTenure (approx.)Committees / Impact
GigPeak (GigOptix)Founder, Chairman, CEO & President; sold to IDT for $250M cash2007–2017Led ~10 M&A deals; executed sale to IDT in Apr 2017 .
GigCapital (GIG1) → Kaleyra (KLR)Executive Chair/CEO/Secretary; later Chair & Secretary of Kaleyra2017 IPO; de‑SPAC 2019; Kaleyra sold to Tata Nov 2023 (~$320M EV)Led restructurings/refis; mGage acquisition ($225M) in 2021 .
GigCapital2 (GIG2) → UpHealth (UPH/UPHL)CEO (initially), Executive Chair/Secretary; later Co‑Chair then ChairIPO 2019; de‑SPAC Jun 2021; Chair 2022Drove restructurings and divestitures (IGI $56M Jun 2023; Cloudbreak $180M Mar 2024) .
GigCapital3 (GIG3) → Lightning eMotors (ZEV/ZEVY)CEO/Exec Chair/Secretary; then Co‑Chair post‑mergerIPO May 2020; de‑SPAC May 2021; exited Oct 2021Guided transition through de‑SPAC; did not stand for reelection Oct 2021 .
GigCapital4 (GIG4) → BigBear.ai (BBAI)Executive Chairman pre‑merger; director post‑mergerIPO Feb 2021; merger closed Dec 9, 2021; director until Mar 2024Oversight during de‑SPAC and transition to NYSE listing .
GigInternational1 (GIW)Executive ChairmanIPO May 2021; liquidated/delisted late 2022Oversaw wind‑down and trust liquidation .
IntransaCEO, President, Director2003–2005Operating leadership .
Equator TechnologiesCEO, President, Director2000–2003Operating leadership .
AT&T Bell LaboratoriesMember of Technical Staff1988–1994R&D leadership .

External Roles

OrganizationRoleDates / StatusNotes
GIG7 (GigCapital7) (Nasdaq: GIG)CEO & ChairmanFounded May 2024; IPO Aug 2024 ($200M)Ongoing SPAC leadership .
GigAcquisitions5 (founding stockholder of QTIH)Sole manager (until dissolution)Through Mar 2025Founding stockholder dissolved Mar 2025 .
GigManagement, LLCManaging member (50% interest)Since inceptionSponsor/management entity .
NY Philharmonic CompanyBoard memberOngoingPhilanthropic board service .
BigBear.ai (NYSE: BBAI)Director (post‑merger)Dec 2021–Mar 2024Former director .
UpHealth (OTC: UPHL)Chair of the BoardSince Jun 2022Led divestitures and refis .
Kaleyra (formerly NYSE: KLR)Chairman & SecretaryNov 2019–Nov 2023Company sold to Tata Communications .
Lightning eMotors (OTC: ZEVY)Co‑Chair (post‑merger)May–Oct 2021Exited board Oct 2021 .

Board Governance

  • Board structure and independence
    • Classified board (3 classes); QTIH notes classification may delay/prevent changes in control .
    • Seven directors; Dr. Katz, Dr. Dinu (CEO), and Dr. Klock are not independent; other four directors are independent under Nasdaq rules .
  • Leadership and committees
    • Chairman: Dr. Katz; policy separates Chair and CEO roles, but Chair is not independent .
    • Executive sessions occur regularly; the Chair (Dr. Katz) has presided, rather than a lead independent director; the proxy does not identify a Lead Independent Director .
    • Committees (all-independent membership): Audit (Chair Ross Taylor; members James Greene, Prof. Zeev Weiner), Compensation (Chair James Greene; members Daniel Dickson, Ross Taylor, Prof. Weiner), Nominating & Corporate Governance (Chair Prof. Weiner; members Ross Taylor, James Greene, Daniel Dickson). Dr. Katz serves on no board committees .
  • Attendance and activity
    • Board held 6 meetings in FY2024; each incumbent director attended at least 75% of board and committee meetings .

Governance implications:

  • Positives: majority-independent board; fully independent, properly chaired committees; clear committee charters; regular executive sessions .
  • Concerns: non‑independent Chair married to CEO; Chair presides over “independent” executive sessions; classified board; potential perception risks around sponsor ties (GigAcquisitions5, GigManagement) .

Fixed Compensation

Component (Director)FY2024 AmountDetail
Cash fees$52,490$24,226 director fee + $28,264 Chair premium .
Equity (options, grant date fair value)$18,92040,000 options granted 7/3/2024; FV $0.47/option .
Total$71,410Sum of cash and equity .

Option grant details (FY2024):

  • Grant: 40,000 stock options on July 3, 2024; exercise price $0.748; vesting: one‑third on Feb 15, 2025, remainder vests quarterly over two years thereafter; grant date fair value $0.47 per option .

Performance Compensation

FeatureDisclosed Terms
Director performance metricsNo performance-vesting metrics disclosed for directors; equity awards are time‑based stock options .
Vesting schedule1/3 vests 2/15/2025; remaining 2/3 quarterly over 2 years .

Note: The proxy’s pay‑for‑performance discussion and annual bonus metrics (revenue and cash balance) apply to NEOs, not to non‑employee directors like Dr. Katz .

Other Directorships & Interlocks

CompanyRoleInterlock/Conflict Considerations
QTIHChairman; spouse is CEO (Dr. Dinu)Spousal relationship; Board deems Dr. Katz not independent .
GigAcquisitions5 (founding stockholder)Sole manager (until dissolution Mar 2025)Founding stockholder role; entity dissolved Mar 2025 .
GigManagement, LLC50% member; managing memberSponsor economics could be perceived as potential conflict if transactions arise; disclosure in proxy .
UpHealth (UPHL)Chair of BoardSeparate company; no QTIH transactional ties disclosed .
BigBear.ai (BBAI)Former director (until Mar 2024)No QTIH transactional ties disclosed .
Kaleyra (KLR)Former Chair & Secretary (sold 2023)Historical role; no QTIH ties disclosed .

Expertise & Qualifications

  • Deep TMT/operator and capital markets background; repeated SPAC sponsorships and complex restructurings (e.g., Kaleyra, UpHealth, Lightning eMotors, BigBear.ai) .
  • Technologist with numerous U.S./international patents and 350+ scientific/technical publications; prior AT&T Bell Labs R&D role .
  • Advanced education: B.Sc. and Ph.D. in Materials (Technion); military academy credentials .

Equity Ownership

HolderBeneficial Ownership% OutstandingComposition / Notes
Dr. Avi S. Katz1,876,351 shares6.4%Includes 136,875 options and 571,431 warrants exercisable within 60 days .

Additional notes:

  • As of record date July 16, 2025, 28,710,144 common shares outstanding .
  • Section 16(a) compliance: all directors/officers filed July 3, 2024 option grants 1–2 days late (July 4 holiday); Dr. Katz and Dr. Dinu each reported a September 2024 fund distribution one day late .
  • Insider trading policy disclosed; corporate governance and committee charters available online; the proxy excerpt does not specify director stock ownership guidelines or pledging prohibitions .

Governance Assessment

  • Board effectiveness: Independent committees with designated financial expert on Audit (Ross Taylor) and clear charters enhance oversight . Attendance threshold met by all directors in FY2024 .
  • Independence and conflicts: Dr. Katz is not independent and is married to the CEO; combined with a classified board and the Chair presiding over executive sessions, this can present perception and structural governance risks (entrenchment, limited independent counterweight) despite majority‑independent board and separated CEO/Chair titles .
  • Ownership alignment: Meaningful beneficial stake (6.4%) with additional near‑term exercisable options and warrants suggests alignment; however, absence of disclosed director ownership guidelines and late Section 16 filings (albeit minor and explained) warrant monitoring .
  • Related‑party exposure: Prior sponsor entities (GigAcquisitions5, GigManagement) are disclosed; QTIH maintains a related‑party transaction policy with Audit Committee pre‑approval and oversight .
  • Say‑on‑pay: QTIH is an Emerging Growth Company and is exempt from advisory say‑on‑pay and CEO pay ratio disclosures, reducing shareholder feedback on compensation structures in the near term .

RED FLAGS to monitor:

  • Non‑independent Chair presiding over “independent” executive sessions; consider appointment of a Lead Independent Director to chair executive sessions .
  • Spousal relationship between Chair and CEO (perceived conflict) .
  • Classified board structure potentially deters accountability/change in control .
  • Minor late Section 16 filings (remain vigilant) .

Positive signals:

  • Majority‑independent board and fully independent key committees; Audit Committee includes an SEC‑defined “financial expert” .
  • Strong transaction/M&A and capital markets expertise relevant to QTIH’s growth and financing strategy .
  • Regular executive sessions and clear committee risk oversight delineation .